Showing results (221-230 of 5,668) with videos related to
Sort By:
Pageof 567
The Oncologist|October 1, 2022
A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 StudyYusuke Chihara, Takayuki Takeda, Yasuhiro Goto, et al.The Oncologist|October 6, 2022
Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific SignaturesMohamed A Gouda, Dzifa Y Duose, Morten Lapin, et al.The Oncologist|February 15, 2021
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell TumorsSamuel A Funt, Deaglan J McHugh, Stephanie Tsai, et al.The Oncologist|March 6, 2021
De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) TrialBrett A Miles, Marshall R Posner, Vishal Gupta, et al.The Oncologist|March 8, 2021
Novel SLC12A2-ROS1 Fusion in Non-Small Cell Lung Cancer with a Significant Response to Crizotinib: The Importance of Choosing the Appropriate Next-Generation Sequencing AssayCarlos Rodríguez-Antolín, Rocío Rosas-Alonso, Patricia Cruz, et al.The Oncologist|June 3, 2011
Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancerNaoki Niikura, Jun Liu, Colleen M Costelloe, et al.The Oncologist|June 3, 2011
Cutaneous melanoma in situ: translational evidence from a large population-based studySimone Mocellin, Donato NittiThe Oncologist|June 3, 2011
Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolismMaarten J Deenen, Annemieke Cats, Jos H Beijnen, et al.The Oncologist|June 18, 2011
Different annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer surveillance after breast-conserving surgeryKe-Da Yu, Shuang Li, Zhi-Ming ShaoThe Oncologist|June 28, 2011
Current targeted therapies in breast cancer: clinical applications in the elderly womanJean-Philippe Spano, Claire Falandry, Pascal Chaibi, et al.Pageof 567